Novel heteroaryl derivative
AssigneeDanippon Sumitomo Pharma Co., Ltd.
InventorsKen-ichi WATANABE, Katsunori Maruta, Kantaro Ushiroda, Ryu Nagata
Life of this patent
Estimating the term…
Abstract
A heteroaryl derivative of the formula (1): (wherein Ring Z is an optionally substituted heteroaryl, R1 is a carboxyl group or an alkoxycarbonyl group, etc., W1 and W2 are an optionally substituted lower alkylene, Ar1 is an optionally substituted arylene or an optionally substituted heteroarylene, W3 is a single bond, a lower alkylene, a lower alkenylene, etc., W4 is a single bond, —NR10—, etc., Ar2 is an optionally substituted aryl or an optionally substituted heteroaryl), or a prodrug thereof, or a pharmaceutically acceptable salt thereof.
Claims17
A heteroaryl derivative of the formula (1):
- wherein Ring Z is an optionally substituted heteroaryl;
- R1 is a carboxyl group, an alkoxycarbonyl group, an optionally substituted carbamoyl group, an optionally substituted cyclic aminocarbonyl group, an optionally substituted alkylsulfonylcarbamoyl group, an optionally substituted arylsulfonylcarbamoyl group, or a tetrazolyl group;
- W1 and W2 are an optionally substituted lower alkylene;
- Ar1 is an optionally substituted arylene or an optionally substituted heteroarylene;
- W3 is a single bond, a lower alkylene, a lower alkenylene, or —Y1—W5— in which Y1 is an oxygen atom, a sulfur atom, —S(O)— or —S(O)2—, and W5 is a lower alkylene or a lower alkenylene;
- W4 is a single bond, —NR10—, —NR10—W6—, in which R10 is a hydrogen atom, or an optionally substituted lower alkyl, and W6 is a lower alkylene), a lower alkylene, or a lower alkenylene;
- Ar2 is an optionally substituted aryl or an optionally substituted heteroaryl,
- or a prodrug thereof, or a pharmaceutically acceptable salt thereof.
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.